Disorders of serum omega-3 fatty acid composition in dialyzed patients, and their associations with fat mass

25Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular mortality. Lipid disorders, a constant feature of CKD, might contribute to this state. The aim of this study was to evaluate n-3 polyunsaturated fatty acids (PUFA) composition in CKD patients treated with dialysis, in comparison to the general population and to assess possible associations between the n-3 PUFA profile and anthropometric variables. Thirty-three prevalent dialysis patients were studied and compared with an age-and sex-adjusted control group of 22 patients. Fatty acid composition in serum was analyzed by gas chromatography with a mass spectrometer detector (GC-MS) and anthropometric measures were assessed by bioimpedance spectroscopy. The fatty acid profile of dialyzed patients was characterized by a significantly lower percentage content of n-3 PUFA. For α-linolenic acid (ALA), it was 0.21±0.09% in dialysis patients versus 0.33±0.11% in the control group (p

Cite

CITATION STYLE

APA

Sikorska- Wiśniewska, M., Mika, A., Śledziński, T., Małgorzewicz, S., Stepnowski, P., Rutkowski, B., & Chmielewski, M. (2017). Disorders of serum omega-3 fatty acid composition in dialyzed patients, and their associations with fat mass. Renal Failure, 39(1), 406–412. https://doi.org/10.1080/0886022X.2017.1295870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free